Efficacy and Safety of Dexlansoprazole on Heartburn Relief in Chinese Patients

Summary

The purpose of this study is to determine the efficacy and safety of dexlansoprazole compared to placebo in relief of daytime and nighttime heartburn over 4 weeks in Chinese participants with symptomatic non-erosive Gastroesophageal Reflux Disease (GERD).

Timeline

Start

2016-12-27

Primary completion

2018-03-14

Completion

2018-04-19

Outcome

Missed primary endpoint

registry analysis (superiority test); Placebo vs Dexlansoprazole 30 mg; p = 0.057; Wilcoxon rank-sum test NCT02873689 ↗

Drugs

Indications